@article{b4a6cb34dbec4d988f3c708eecb244d4,
title = "Diverging consequences of hexosamine biosynthesis in cardiovascular disease",
keywords = "Cardiac hypertrophy, Diabetes related cardiomyopathy, Heart failure, Hexosamine biosynthetic pathway, Metabolic remodeling, Myocardial infarction, O-GlcNAcylation, Pressure overload",
author = "Qinfeng Li and Heinrich Taegtmeyer and Wang, {Zhao V.}",
note = "Funding Information: We thank members of our labs for valuable discussions. This work was supported by grants from the American Heart Association (14SDG18440002, 17IRG33460191, and 19IPLOI34760325 to Z.V.W.), the American Diabetes Association (1-17-IBS-120 and 7-20-IBS-218 to Z.V.W.), and NIH (R01-HL137723 to Z.V. W. and R01-HL061483 to H.T.).",
year = "2021",
month = apr,
doi = "10.1016/j.yjmcc.2020.12.016",
language = "English (US)",
volume = "153",
pages = "104--105",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
}